Jubilant Pharmova Limited (JUBLPHARMA.NS)
INR 918.3
(10.89%)
INR 918.3
(10.89%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 5.18 Billion INR | 38.42% |
| 2022 | 3.74 Billion INR | -55.36% |
| 2021 | 8.39 Billion INR | -26.6% |
| 2020 | 11.44 Billion INR | -7.63% |
| 2019 | 12.38 Billion INR | -10.37% |
| 2018 | 13.82 Billion INR | 24.8% |
| 2017 | 11.07 Billion INR | 3.18% |
| 2016 | 10.73 Billion INR | 14.09% |
| 2015 | 9.4 Billion INR | 133.77% |
| 2014 | 4.02 Billion INR | -44.73% |
| 2013 | 7.28 Billion INR | -10.1% |
| 2012 | 8.09 Billion INR | 17.84% |
| 2011 | 6.87 Billion INR | 83.53% |
| 2010 | 3.74 Billion INR | -43.98% |
| 2009 | 6.68 Billion INR | 21.59% |
| 2008 | 5.49 Billion INR | 12.07% |
| 2007 | 4.9 Billion INR | 108.46% |
| 2006 | 2.35 Billion INR | 26.92% |
| 2005 | 1.85 Billion INR | 28.5% |
| 2004 | 1.44 Billion INR | 10.12% |
| 2003 | 1.31 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 655 Million INR | -61.56% |
| 2024 Q2 | 1.98 Billion INR | 202.29% |
| 2023 Q1 | 799 Million INR | 359.0% |
| 2023 Q3 | 1.72 Billion INR | 5.0% |
| 2023 Q2 | 1.64 Billion INR | 105.38% |
| 2023 Q4 | 1.7 Billion INR | -1.1% |
| 2023 FY | 5.18 Billion INR | 38.42% |
| 2022 Q2 | 1.35 Billion INR | 38.24% |
| 2022 FY | 3.74 Billion INR | -55.36% |
| 2022 Q4 | -308.5 Million INR | -151.92% |
| 2022 Q3 | 594.2 Million INR | -56.06% |
| 2022 Q1 | 978.3 Million INR | -33.36% |
| 2021 FY | 8.39 Billion INR | -26.6% |
| 2021 Q4 | 1.46 Billion INR | 45.48% |
| 2021 Q1 | 2.87 Billion INR | -20.12% |
| 2021 Q3 | 1 Billion INR | -57.91% |
| 2021 Q2 | 2.39 Billion INR | -16.53% |
| 2020 Q2 | 3.7 Billion INR | 95.0% |
| 2020 FY | 11.44 Billion INR | -7.63% |
| 2020 Q4 | 3.59 Billion INR | -9.4% |
| 2020 Q1 | 1.89 Billion INR | -53.73% |
| 2020 Q3 | 3.96 Billion INR | 7.15% |
| 2019 Q1 | 3.31 Billion INR | 19.87% |
| 2019 FY | 12.38 Billion INR | -10.37% |
| 2019 Q2 | 3.51 Billion INR | 5.94% |
| 2019 Q3 | 3.93 Billion INR | 12.04% |
| 2019 Q4 | 4.1 Billion INR | 4.18% |
| 2018 Q1 | 3.49 Billion INR | 26.61% |
| 2018 Q4 | 2.76 Billion INR | -29.88% |
| 2018 FY | 13.82 Billion INR | 24.8% |
| 2018 Q3 | 3.94 Billion INR | 9.47% |
| 2018 Q2 | 3.6 Billion INR | 3.18% |
| 2017 Q1 | 2.65 Billion INR | 14.94% |
| 2017 FY | 11.07 Billion INR | 3.18% |
| 2017 Q4 | 2.76 Billion INR | -17.58% |
| 2017 Q3 | 3.35 Billion INR | 47.55% |
| 2017 Q2 | 2.27 Billion INR | -14.36% |
| 2016 Q3 | 2.44 Billion INR | -1.03% |
| 2016 Q4 | 2.3 Billion INR | -5.81% |
| 2016 Q2 | 2.47 Billion INR | -12.37% |
| 2016 FY | 10.73 Billion INR | 14.09% |
| 2016 Q1 | 2.82 Billion INR | 69.93% |
| 2015 FY | 9.4 Billion INR | 133.77% |
| 2015 Q1 | 2.42 Billion INR | 33.03% |
| 2015 Q2 | 2.31 Billion INR | -4.61% |
| 2015 Q3 | 1.93 Billion INR | -16.54% |
| 2015 Q4 | 1.66 Billion INR | -14.05% |
| 2014 Q3 | 966.3 Million INR | 63.12% |
| 2014 Q4 | 1.82 Billion INR | 88.91% |
| 2014 Q2 | 592.4 Million INR | -7.45% |
| 2014 FY | 4.02 Billion INR | -44.73% |
| 2014 Q1 | 640.1 Million INR | -72.68% |
| 2013 FY | 7.28 Billion INR | -10.1% |
| 2013 Q4 | 2.34 Billion INR | 41.0% |
| 2013 Q3 | 1.66 Billion INR | -14.04% |
| 2013 Q2 | 1.93 Billion INR | 119.18% |
| 2013 Q1 | -10.08 Billion INR | -609.69% |
| 2012 Q3 | 1.95 Billion INR | -4.18% |
| 2012 FY | 8.09 Billion INR | 17.84% |
| 2012 Q4 | 1.97 Billion INR | 1.11% |
| 2012 Q2 | 2.04 Billion INR | 122.74% |
| 2012 Q1 | -8.97 Billion INR | -521.33% |
| 2011 FY | 6.87 Billion INR | 83.53% |
| 2011 Q3 | 1.53 Billion INR | 0.0% |
| 2011 Q4 | 2.13 Billion INR | 38.8% |
| 2010 FY | 3.74 Billion INR | -43.98% |
| 2009 FY | 6.68 Billion INR | 21.59% |
| 2008 FY | 5.49 Billion INR | 12.07% |
| 2007 FY | 4.9 Billion INR | 108.46% |
| 2006 FY | 2.35 Billion INR | 26.92% |
| 2005 FY | 1.85 Billion INR | 28.5% |
| 2004 FY | 1.44 Billion INR | 10.12% |
| 2003 FY | 1.31 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 9.883% |
| Hester Biosciences Limited | 364.77 Million INR | -1322.54% |
| Aarti Drugs Limited | 7.14 Billion INR | 27.414% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -65.883% |
| Albert David Limited | 1.33 Billion INR | -288.847% |
| Alembic Limited | 767.77 Million INR | -575.853% |
| Alkem Laboratories Limited | 19.46 Billion INR | 73.338% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -2083.362% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -25021.03% |
| Brooks Laboratories Limited | -72.25 Million INR | 7281.808% |
| Eris Lifesciences Limited | 5.18 Billion INR | -0.14% |
| FDC Limited | 3.03 Billion INR | -71.043% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 42.211% |
| Gufic Biosciences Limited | 2.89 Billion INR | -79.314% |
| Hikal Limited | 1.49 Billion INR | -247.276% |
| Ind-Swift Limited | 1.22 Billion INR | -323.259% |
| Innova Captab Limited | 2.53 Billion INR | -104.823% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -4.994% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -2324.313% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -172.199% |
| Lupin Limited | 27.75 Billion INR | 81.306% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -18797.953% |
| Medico Remedies Limited | 277.11 Million INR | -1772.488% |
| Morepen Laboratories Limited | 4.17 Billion INR | -24.322% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -33.373% |
| Orchid Pharma Limited | 2.36 Billion INR | -119.772% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -86.253% |
| RPG Life Sciences Limited | 2.29 Billion INR | -126.367% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -2394.112% |
| Sigachi Industries Limited | 1.47 Billion INR | -252.06% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 234.678% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -12.617% |
| Themis Medicare Limited | 1.3 Billion INR | -298.203% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Vaishali Pharma Limited | 6.29 Million INR | -82343.597% |
| Wanbury Limited | 1.7 Billion INR | -203.947% |
| Windlas Biotech Limited | 1.29 Billion INR | -299.495% |
| ZIM Laboratories Limited | 1.09 Billion INR | -372.538% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -158.283% |
| Ipca Laboratories Limited | 29.59 Billion INR | 82.468% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 95.025% |
| Venus Remedies Limited | 534.65 Million INR | -870.54% |
| Sakar Healthcare Limited | 495.5 Million INR | -947.212% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 95.035% |
| Divi's Laboratories Limited | 18.31 Billion INR | 71.66% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -15.984% |
| Mankind Pharma Limited | 40.86 Billion INR | 87.303% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Laurus Labs Limited | 3.94 Billion INR | -31.414% |
| Neuland Laboratories Limited | 5.31 Billion INR | 2.427% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 31.195% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 20.198% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 88.568% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -735.551% |
| Wockhardt Limited | 140 Million INR | -3606.429% |
| Bal Pharma Limited | 214.56 Million INR | -2318.336% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 92.339% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -321.527% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -840.737% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 28.183% |
| Shilpa Medicare Limited | 3.76 Billion INR | -37.948% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Ajanta Pharma Limited | 19.67 Billion INR | 73.63% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -183203.389% |
| Granules India Limited | 6.52 Billion INR | 20.515% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -1981.837% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 79.519% |
| NATCO Pharma Limited | 25.96 Billion INR | 80.013% |
| Suven Life Sciences Limited | -1.22 Billion INR | 523.308% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | 0.704% |
| Indoco Remedies Limited | 1.52 Billion INR | -240.396% |
| Alpa Laboratories Limited | 61.51 Million INR | -8335.341% |
| Lasa Supergenerics Limited | -458 Million INR | 1232.957% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 226.098% |